Results · Apr-Jun 2026
Skybiotech Healthcare Q1 FY27 results
Sales fell 79% to ₹0.49 crore from ₹2.4 crore in Apr-Jun 2025.
Operating profit fell 814% to −₹0.52 crore, an operating margin of −106.4% (down 109.5 points from a year ago).
The net loss widened to ₹0.57 crore from ₹0.02 crore.
Against Jan-Mar 2026: sales −73%, loss widens.
Apr-Jun 2026 vs a year ago
| ₹ crore | Apr-Jun 2026 | Apr-Jun 2025 | Change |
|---|---|---|---|
| Sales | 0.5 | 2.4 | −79% |
| Operating profit (EBITDA) | -0.5 | 0.1 | −814% |
| Operating margin | −106.4% | 3.1% | −109.5 pts |
| Net profit | -0.6 | -0.0 | loss widens |
Consolidated figures. Margins & ratios change in percentage points (pts).
The last 7 quarters
From the company's results filed on BSE (Consolidated). Business numbers only. Education & analysis, not investment advice or a recommendation.